Literature DB >> 15137933

Immune cellular response to HPV: current concepts.

Maria Alice Guimarães Gonçalves1, Eduardo Antonio Donadi.   

Abstract

Although cellular immunity is essential for the elimination of human papillomavirus (HPV), the mechanisms involved are still poorly understood. We summarize the main mechanisms involved in cellular immune response to infections caused by HPV. Immunotherapies for HPV-related cancers require the disruption of T-cell response control mechanisms, associated with the stimulation of the Th1 cytokine response.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15137933

Source DB:  PubMed          Journal:  Braz J Infect Dis        ISSN： 1413-8670            Impact factor:   1.949


  17 in total

Review 1.  An armamentarium of wart treatments.

Authors:  Michelle M Lipke
Journal:  Clin Med Res       Date:  2006-12

2.  Therapeutic Outcome of Intralesional Immunotherapy in Cutaneous Warts Using the Mumps, Measles, and Rubella Vaccine: A Randomized, Placebo-controlled Trial.

Authors:  Guneet Awal; Simplepreet Kaur
Journal:  J Clin Aesthet Dermatol       Date:  2018-05-01

3.  Local lymphocytes and nitric oxide synthase in the uterine cervical stroma of patients with grade III cervical intraepithelial neoplasia.

Authors:  Cléber Sergioda da Silva; Marcia Antoniazi Michelin; Renata Margarida Etchebehere; Sheila Jorge Adad; Eddie Fernando Candido Murta
Journal:  Clinics (Sao Paulo)       Date:  2010-06       Impact factor: 2.365

Review 4.  The potential applications of T cell receptor (TCR)-like antibody in cervical cancer immunotherapy.

Authors:  Sylvia Annabel Dass; Rehasri Selva Rajan; Gee Jun Tye; Venugopal Balakrishnan
Journal:  Hum Vaccin Immunother       Date:  2021-05-14       Impact factor: 3.452

5.  Combining agent based-models and virtual screening techniques to predict the best citrus-derived vaccine adjuvants against human papilloma virus.

Authors:  Marzio Pennisi; Giulia Russo; Silvia Ravalli; Francesco Pappalardo
Journal:  BMC Bioinformatics       Date:  2017-12-28       Impact factor: 3.169

6.  Human papillomavirus infection in oral fluids of HIV-1-positive men: prevalence and risk factors.

Authors:  Karen Gaester; Luiz A M Fonseca; Olinda Luiz; Tatiane Assone; Adriele Souza Fontes; Fernando Costa; Alberto J S Duarte; Jorge Casseb
Journal:  Sci Rep       Date:  2014-10-17       Impact factor: 4.379

7.  Bacillus Calmette-Guerin Immunotherapy for Recurrent Multiple Warts: An Open-Label Uncontrolled Study.

Authors:  Avtar Kishan Jaisinghani; Vivek Kumar Dey; M S Suresh; Animesh Saxena
Journal:  Indian J Dermatol       Date:  2019 Mar-Apr       Impact factor: 1.494

8.  Safety and Efficacy of Intralesional Vitamin D3 in Cutaneous Warts: An Open Uncontrolled Trial.

Authors:  Manjunath Kavya; Basavapura Madegowda Shashikumar; Muddanahalli Rajegowda Harish; Bhadbhade P Shweta
Journal:  J Cutan Aesthet Surg       Date:  2017 Apr-Jun

9.  Intralesional Injection of the Measles-Mumps-Rubella Vaccine into Resistant Palmoplantar Warts: A Randomized Controlled Trial.

Authors:  Mohammad Sadegh Rezai; Hiva Ghasempouri; Ozra Asqary Marzidareh; Jamshid Yazdani Cherati; Ghasem Rahmatpour Rokni
Journal:  Iran J Med Sci       Date:  2019-01

10.  A Randomized Comparative Study of MIP and MMR Vaccine for the Treatment of Cutaneous Warts.

Authors:  Amandeep Kaur; Balvinder Kaur Brar; Sumir Kumar; Sukhmani Kaur Brar; Amarbir Singh Boparai; Neerja Puri
Journal:  Indian J Dermatol       Date:  2021 Mar-Apr       Impact factor: 1.494
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.